Lynn Webster, MD, Executive Vice President of Scientific Affairs, recently presented his poster titled “A Review of the Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride...
Our Executive Vice President of Scientific Affairs, Dr. Lynn Webster, has released a co-authored review on opioid abuse-deterrent formulations (ADFs). This comprehensive analysis delves into the effectiveness of ADFs in reducing misuse and abuse while highlighting the...
Recent Comments